
1. j clin microbiol. 2004 dec;42(12):5604-8.

genetic profile oka varicella vaccine virus variant isolated infant
with zoster.

sauerbrei a(1), rubtcova e, wutzler p, schmid ds, loparev vn.

author information: 
(1)institute virology antiviral therapy, friedrich-schiller university,
jena, germany.

comment in
    j clin microbiol. 2005 oct;43(10):5415-6; author reply 5416-7.

varicella virus vaccine strain oka (v-oka) rare cases caused zoster in
vaccinated people. despite broad usage v-oka, little known about
varicella-zoster virus genomic sequence variation strains vaccine and
isolates patients vaccine adverse events. direct sequencing 20
regions v-oka-gsk compared sequences original v-oka-biken,
glaxosmithkline oka vaccine (v-oka-gsk), oka-parental (p-oka) strains. we
analyzed single nucleotide polymorphisms (snp) differentiating oka parental
and oka vaccine strains identified open reading frames (orfs) 6, 9a, 10, 21,
31, 39, 50, 51, 52, 54, 55, 59 eight base substitutions within orf 62.
sixteen snp impose amino acid change corresponding gene
product. genotypic analysis revealed (i) v-oka-gsk v-oka-biken 
comprise mixtures strains represented variable proportion lot lot; 
(ii) v-oka-gsk/zoster isolated zoster patient six wild-type snp in
orf 9a, 10, 21, 52, 55, 62 (mutation 108838); (iii) none six revertant
snp would reliably discriminate oka vaccine wild type; (iv) the
genomic variation found v-oka/zoster might associated changes the
biological behavior virus. studies needed identify
potential virulence factors variant vaccine strains.

doi: 10.1128/jcm.42.12.5604-5608.2004 
pmcid: pmc535228
pmid: 15583288  [indexed medline]

